SecBot SecBot
Insider Cluster (2 insiders) ·Filed Sep 18, 2026

SKYE

Skye Bioscience, Inc.
BEARISH
Impact 4/10
Horizondays Processed1mo ago
Insider cluster: 2 insiders, $125K total
Actionable Insight ▼ Bearish

The dollar amount is too small to signal material non-public information. Monitor for any upcoming clinical or regulatory catalysts (Skye is a biotech) that could explain the selling, but treat this as routine portfolio trimming by 10% owners.

DirectionBearish
Confidencemedium
Horizondays
Latest settled — T+20d
SKYE ▼ -14.04% at T+20d
SHORT call ✓ call won +14.04% · α vs SPY +13.14% · entry $1.78 → $1.53
Next anchor: T+60d in 7w
Latest observation: T+24 -35.48% FF3 residual α
Entry = T+0 close
Sep 18, 2026
via day close
T+1d
-3.93%
call +3.93% · α +3.92%
$1.71
settled 5w ago
T+5d
-9.55%
call +9.55% · α +8.53%
$1.61
settled 4w ago
T+20d
-14.04%
call +14.04% · α +13.14%
$1.53
settled 10d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

Two 10% owners of Skye Bioscience sold a combined $125K in open-market sales at $1.91/share within a 7-day window. The total value is ~0.04% of the company's $326M market cap, making this a trivial insider cluster. No C-suite involvement and no 10b5-1 plan indication, but the sales are open-market (code S) and cluster together, warranting a modest bearish tilt.

Key Financial Metrics

Direction
selling
Total Value
$125.0K
Insiders
2

Key Facts

  • Two 10% owners (Andrew J. Schwab and 5AM Partners VII, LLC) sold a combined 65,214 shares at $1.91/share for total proceeds of ~$125K.
  • Sales occurred on 2026-09-16, within a 7-day cluster window.
  • Total sale value represents ~0.04% of Skye's $326M market cap — well below the 0.1% materiality threshold.
  • No C-suite executives participated; no 10b5-1 plan indicated.

Financial Impact

~$125K in insider sales, ~0.04% of market cap

dilutioninsider sentiment

Risk Factors

  • Insider selling by 10% owners could precede negative news, though the small size limits this risk.
  • Biotech volatility means any clinical trial readout could overshadow insider activity.

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-SKYE-1789771192415
14 reports for SKYE
Performance horizon
100% Hit rate @ T+20 4 of 4 directional calls Went positive at some point 4 of 4 best @ T+20▲ +50.40%Aug 14, 2026
Filters
Rows
Reports for SKYE — sortable, filterable
TypeNow
Oct 26, 2026
today
PREM14A
BEARISH ★ 7/10
—awaiting T+20——
Oct 14, 2026
12d ago
SC 13G
NEUTRAL ★ 4/10
$1.59awaiting T+20—$1.57 (−1.26%)
Sep 24, 2026
4w ago
Insider Cluster
NEUTRAL ★ 3/10
$1.67 $1.54▼ −7.78%▼ −6.31%$1.57 (−5.99%)
Sep 24, 2026
4w ago
SC 13D/A
BEARISH ★ 6/10
$1.67 $1.54▲ +7.78%▲ +6.31%$1.57 (+5.99%)
Sep 18, 2026
5w ago
Insider Cluster
BEARISH ★ 4/10
$1.78 $1.53▲ +14.04%▲ +13.14%$1.57 (+11.80%)
Aug 19, 2026
9w ago
DEFA14A
NEUTRAL ★ 4/10
$0.2809 $0.2206▼ −21.46%▼ −21.34%$1.57 (+458.92%)
Aug 14, 2026
10w ago
8-K
MIXED ★ 7/10
$0.5015 $0.2487▼ −50.40%▼ −48.41%$1.57 (+213.06%)
Aug 14, 2026
10w ago
Press Release
BEARISH ★ 7/10
$0.5015 $0.2487▲ +50.40%▲ +48.41%$1.57 (−213.06%)
May 15, 2026
23w ago
8-K
BEARISH ★ 7/10
$0.7780 $0.7184▲ +7.66%▲ +9.24%$1.57 (−101.80%)
May 12, 2026
23w ago
Press Release
BEARISH ★ 7/10
$0.8140 $0.7800▲ +4.18%▲ +2.45%$1.57 (−92.87%)
Showing 10 of 14

US Market Status

Market Closed — Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 18, 2026